作者: Wild Js , Giri Sn , Schiedt Mj , Margolin Sb , Iyer Sn
DOI:
关键词: Bleomycin 、 Pulmonary fibrosis 、 Lung 、 Pathology 、 Pirfenidone 、 Toxicity 、 Pharmacology 、 Medicine 、 Fibrosis 、 Hydroxyproline 、 Respiratory disease
摘要: There are no clinically efficacious drugs available for preventing the development of pulmonary fibrosis (PF). In the present study, we tested the antifibrotic potential of pirfenidone (PD) in the bleomycin (BL) hamster model of PF. Hamsters were intratracheally instilled with isotonic saline solution or BL (7.5 U/kg/5 ml). The animals were fed control diet containing 0.5% PD or the same diet without the drug 2 days before and throughout the study. The four groups were as follows: saline-instilled and fed the control diet (SCD); saline …